Biocatalysts Ltd is a world leader in specialty enzyme manufacturing for the food processing and other industries. Its enzyme technology production is used to improve processed food shelf life, quality and enhance flavour and is part of the supply chain to seven of the top ten global food companies. Located in Nantgarw, Cardiff, the company has expanded its enzyme production plant with the help of a £6.5 million investment from Barclays which has facilitated the building of a 11,000 square foot extension to the existing site together with significant investment in new plant, to treble manufacturing capacity at the site.
“Biocatalysts expands its South Wales site.“
Biocatalysts Ltd’s Stuart West, said: “After 25 years as Managing Director I now step into my new role as Non Exec Director from Jan 2019. The business has grown rapidly in recent years with continued support from Barclays backing our continued growth strategy, and the new enzyme plant will allow us to significantly increase production and expand into new markets. We have previously been outsourcing production to Eastern Europe but the new unit will allow us to bring production back in house. Enzyme development has moved from the labs to the laptops as computer processing power now enables us to rapid prototype and develop new bespoke enzymes in months rather than years. We currently export around 80% of our product right round the world to South America, the Far East and with the US being our biggest export market. We have created a US subsidiary Biocatalysts Inc to accommodate the demand from the US. as there is still huge potential in the US market as their demand for quality processed food continues to soar. The new plant will allow to diversify our enzyme manufacturing into the pharmaceutical sector and baking industry.”